<DOC>
	<DOCNO>NCT00769119</DOCNO>
	<brief_summary>The purpose study investigate treatment AZD9668 28 day effective treating Bronchiectasis ( Brx ) compare placebo ( substance action ) .</brief_summary>
	<brief_title>A Phase II , Placebo-controlled Study Assess Efficacy 28 Day Oral AZD9668 Patients With Bronchiectasis</brief_title>
	<detailed_description />
	<mesh_term>Bronchiectasis</mesh_term>
	<criteria>Female non child bearing potential Clinical diagnosis bronchiectasis Be sputum producer , history chronic expectoration day Concomitant diagnosis pulmonary disease bronchiectasis COPD FEV1 &lt; 30 % predict normal</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>bronchiectasis</keyword>
	<keyword>Phase II</keyword>
</DOC>